Phase Holographic Imaging is gearing up for growth following a transitional quarter. While sales were impacted by a complex handover of sales operations and market anticipation for new technology, the company has now executed two major strategic moves. With the official launch of Holomonitor Next Generation and a dedicated entry into the veterinary IVF market, the company is positioned to capture pent-up demand. CEO Patrik Eschricht emphasises that these milestones provide the foundation to accelerate commercial activities.

Read the full interview at biostock.se:

PHI comments on roadmap with new platform and entry into IVF

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Follow BioStock
Stay up to date with the latest news, upcoming events, recent videos, and podcasts! Subscribe to our newsletters at https://www.biostock.se/newsletter
Follow BioStock on social media: LinkedIn and Facebook!  

About BioStock
BioStock is the leading digital hub for the Nordic life science sector. Focusing on biotechnology, medical technology, diagnostics, and drug development, we provide daily news updates, in-depth analyses, exclusive interviews, and innovation-promoting networking events – all to keep you informed about industry developments.  
BioStock – Connecting Innovation & Capital.